Reckitt Benckiser Group (OTCMKTS:RBGLY) Sets New 52-Week Low at $10.24

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) shares reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $10.24 and last traded at $10.29, with a volume of 1310476 shares traded. The stock had previously closed at $10.34.

Analyst Upgrades and Downgrades

Separately, BNP Paribas upgraded Reckitt Benckiser Group from an “underperform” rating to a “neutral” rating in a research note on Tuesday, January 9th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $6,978.00.

Reckitt Benckiser Group Stock Down 0.5 %

The business’s 50 day moving average price is $12.55 and its two-hundred day moving average price is $13.42.

Reckitt Benckiser Group Increases Dividend

The company also recently disclosed a dividend, which will be paid on Monday, June 3rd. Investors of record on Friday, April 12th will be issued a dividend of $0.2701 per share. This is an increase from Reckitt Benckiser Group’s previous dividend of $0.18. The ex-dividend date of this dividend is Thursday, April 11th.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.